- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05275114
Improvement Effect of Transcranial Direct Current Stimulation (tDCS) Applied During Exercise Training in Stroke Patients With Upper Limb and Hand Motor Function
September 20, 2022 updated by: Yun-Hee Kim
The purpose of this study was to improve the effect of Transcranial Direct Current Stimulation (tDCS) applied during exercise training in stroke patients with upper limb and hand motor function.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 06351
- Samsung Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients aged 19 to 80 years
- Less than 58 FMA Upper scores
- Patients whose lesions do not include stimulation regions
- Patients with stroke with more than 3 months of onset
Exclusion Criteria:
- Difficult to communicate due to severe language impairment.
- Accompanied by an existing serious neurogenic disease
- Existing significant psychiatric disorders such as major schizophrenia, bipolar disorder
- If there are difficulties in conducting the research
- Any patients who are judged by the investigator to be difficult to participate in this study
- Patients with contraindicated MRI scans
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Hand Tasks + M1(1mA) & aIPS(1mA) tDCS
20 minutes of Hand Taks + applying 30 minutes of M1(1mA) & aIPS(1mA) tDCS and fNIRS
|
30 minutes of intervention including tDCS stimulation with hand task and fNIRS measurements for 10 days in 4 weeks
|
|
Active Comparator: Hand Tasks + Sham tDCS
20 minutes of Hand Tasks + 30 minutes of sham tDCS and fNIRS
|
30 minutes of intervention including sham tDCS stimulation with hand task and fNIRS measurements for 10 days in 4 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Fugl-Meyer Assessment
Time Frame: Session 0 (initial visit);; Session 10 (at approximatel 4 weeks)
|
The score is a stroke-specific, performance-based impairment index.
The degree of impairment of upper and lower limbs is measured.
|
Session 0 (initial visit);; Session 10 (at approximatel 4 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in 9-hole pegboard test
Time Frame: Baseline(initial visit); Session 10 (at approximatel 4 weeks)
|
The test is a standardized, quantitative assessment used to measure finger dexterity of a patient.
|
Baseline(initial visit); Session 10 (at approximatel 4 weeks)
|
|
Change in Grip & Tip pinch strength
Time Frame: Baseline(initial visit); Session 10 (at approximatel 4 weeks)
|
The test is to measure the maximum isometric strength of hand, forearm, and finger muscles.
|
Baseline(initial visit); Session 10 (at approximatel 4 weeks)
|
|
Change in Sequential finger tapping reaction time and accruacy
Time Frame: Baseline(initial visit); Session 10 (at approximatel 4 weeks)
|
Response time and accuracy are measured during finger tapping task.
|
Baseline(initial visit); Session 10 (at approximatel 4 weeks)
|
|
Change in Jebsen-Taylor hand function test
Time Frame: Baseline(initial visit); Session 10 (at approximatel 4 weeks)
|
This test is a standardized and objective measure of fine and gross motor hand function using simulated activities of daily living (ADL).
|
Baseline(initial visit); Session 10 (at approximatel 4 weeks)
|
|
Change in Box and Block test
Time Frame: Baseline(initial visit); Session 10 (at approximatel 4 weeks)
|
The test is used to measure the gross manual dexterity of a patient, or of a person using an upper limb prosthetic device.
|
Baseline(initial visit); Session 10 (at approximatel 4 weeks)
|
|
Changes in motor evoked potential
Time Frame: [Time Frame: session 0 (initial visit); session 10 (at approximately 4 weeks)]
|
Resting motor threshold (rMT) and amplitude of motor evoked potential in first dorsal interosseous muscle are measured.
These outcomes are measured by transcranial magnetic stimulation over the motor hotspot.
The rMT is defined as the minimum stimulus intensity that produced a minimal motor evoked response at rest.
The amplitude means peak to peak of the muscle response.
|
[Time Frame: session 0 (initial visit); session 10 (at approximately 4 weeks)]
|
|
Changes in Brain activation of resting-state functional MRI
Time Frame: [Time Frame: session 0 (initial visit); session 10 (at approximately 4 weeks)]
|
Measure of Neuroplasticity
|
[Time Frame: session 0 (initial visit); session 10 (at approximately 4 weeks)]
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 11, 2022
Primary Completion (Actual)
August 31, 2022
Study Completion (Actual)
August 31, 2022
Study Registration Dates
First Submitted
March 1, 2022
First Submitted That Met QC Criteria
March 9, 2022
First Posted (Actual)
March 11, 2022
Study Record Updates
Last Update Posted (Actual)
September 21, 2022
Last Update Submitted That Met QC Criteria
September 20, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-06-176
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.